bluebird bio Inc. (NASDAQ: BLUE)
$8.4050
-0.8250 ( -8.64% ) 512.5K
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.
Market Data
Open
$8.4050
Previous close
$9.2300
Volume
512.5K
Market cap
$89.74M
Day range
$8.2010 - $9.7630
52 week range
$5.8000 - $38.4000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 2 | Oct 02, 2024 |
10-q | Quarterly Reports | 82 | Sep 27, 2024 |
def | Proxies and info statements | 21 | Sep 26, 2024 |
ars | Annual reports | 1 | Sep 26, 2024 |
8-k | 8K-related | 14 | Sep 24, 2024 |
8-k | 8K-related | 13 | Sep 23, 2024 |
pre | Proxies and info statements | 20 | Sep 16, 2024 |
10-q | Quarterly Reports | 82 | Sep 13, 2024 |
10-k | Annual reports | 133 | Sep 13, 2024 |
8-k | 8K-related | 14 | Aug 30, 2024 |